1. Home
  2. VCSA vs ANEB Comparison

VCSA vs ANEB Comparison

Compare VCSA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCSA
  • ANEB
  • Stock Information
  • Founded
  • VCSA 2009
  • ANEB 2020
  • Country
  • VCSA United States
  • ANEB United States
  • Employees
  • VCSA N/A
  • ANEB N/A
  • Industry
  • VCSA Computer Software: Prepackaged Software
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCSA Technology
  • ANEB Health Care
  • Exchange
  • VCSA Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • VCSA 38.6M
  • ANEB 36.7M
  • IPO Year
  • VCSA N/A
  • ANEB 2021
  • Fundamental
  • Price
  • VCSA $3.34
  • ANEB $0.99
  • Analyst Decision
  • VCSA Buy
  • ANEB Buy
  • Analyst Count
  • VCSA 4
  • ANEB 1
  • Target Price
  • VCSA $6.08
  • ANEB $8.00
  • AVG Volume (30 Days)
  • VCSA 79.6K
  • ANEB 18.7K
  • Earning Date
  • VCSA 11-07-2024
  • ANEB 02-11-2025
  • Dividend Yield
  • VCSA N/A
  • ANEB N/A
  • EPS Growth
  • VCSA N/A
  • ANEB N/A
  • EPS
  • VCSA N/A
  • ANEB N/A
  • Revenue
  • VCSA $949,936,000.00
  • ANEB N/A
  • Revenue This Year
  • VCSA N/A
  • ANEB N/A
  • Revenue Next Year
  • VCSA N/A
  • ANEB N/A
  • P/E Ratio
  • VCSA N/A
  • ANEB N/A
  • Revenue Growth
  • VCSA N/A
  • ANEB N/A
  • 52 Week Low
  • VCSA $2.07
  • ANEB $0.80
  • 52 Week High
  • VCSA $11.70
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • VCSA 43.35
  • ANEB 24.99
  • Support Level
  • VCSA $3.75
  • ANEB $1.30
  • Resistance Level
  • VCSA $4.79
  • ANEB $1.39
  • Average True Range (ATR)
  • VCSA 0.41
  • ANEB 0.18
  • MACD
  • VCSA -0.13
  • ANEB -0.03
  • Stochastic Oscillator
  • VCSA 0.00
  • ANEB 23.89

About VCSA Vacasa Inc.

Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: